Wegovy 2.4 mg weekly is the equivalent dose to Ozempic 2 mg weekly
Both Ozempic 2 mg and Wegovy 2.4 mg contain semaglutide as the active ingredient, but they are formulated for different indications and use slightly different maximum doses. Ozempic is FDA-approved for type 2 diabetes at doses up to 2 mg weekly, while Wegovy is FDA-approved for chronic weight management at a maximum dose of 2.4 mg weekly 1, 2, 3.
Understanding the Dose Relationship
The key point is that there is no exact 1:1 equivalent between Ozempic 2 mg and a specific Wegovy dose because:
- Ozempic's maximum approved dose is 2 mg weekly for diabetes management 1, 4
- Wegovy's maximum approved dose is 2.4 mg weekly for obesity/weight management 5, 2, 3
If a patient is on Ozempic 2 mg weekly and needs to transition to Wegovy, the appropriate target dose would be Wegovy 2.4 mg weekly, as this represents the full therapeutic dose for weight management 3.
Clinical Context
Both formulations follow similar dose escalation schedules:
- Start at 0.25 mg weekly
- Escalate through 0.5 mg, 1 mg, 1.7 mg
- Reach maintenance at either 2 mg (Ozempic max) or 2.4 mg (Wegovy max) 1, 3
The 2.4 mg Wegovy dose achieves superior weight loss compared to lower doses (mean 16.9% body weight reduction at 68 weeks in the STEP 1 trial) 2. The 1.7 mg dose is available as an alternative maintenance option for those who cannot tolerate 2.4 mg 3.
Important Caveats
- Do not coadminister Ozempic and Wegovy together or combine with any other GLP-1 receptor agonist 3
- Both products contain the same active ingredient (semaglutide) and should not be used concurrently
- When switching between formulations, maintain the same weekly dosing schedule without overlap
- No dose adjustment is required for renal or hepatic impairment 1, 4